Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
53.23
-0.71 (-1.32%)
At close: Feb 26, 2026
SHA:688193 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 148.2 | 261.58 | 609.57 | 298.93 | 197.94 | 171.98 |
Short-Term Investments | - | 29.2 | 125.66 | - | - | - |
Trading Asset Securities | 635.26 | 510.96 | 50.21 | 530.98 | - | - |
Cash & Short-Term Investments | 783.46 | 801.74 | 785.44 | 829.91 | 197.94 | 171.98 |
Cash Growth | 15.58% | 2.08% | -5.36% | 319.27% | 15.10% | 131.32% |
Accounts Receivable | 47.08 | 49.37 | 77.6 | 105.13 | 55.5 | 39.15 |
Other Receivables | 2.01 | 2.64 | 4.83 | 3.54 | 4.29 | 2.16 |
Receivables | 49.09 | 52.01 | 82.43 | 108.66 | 59.79 | 41.31 |
Inventory | 24.08 | 25.14 | 28.6 | 28.29 | 19.39 | 16.35 |
Other Current Assets | 34.63 | 5.86 | 2.67 | 5.72 | 5.42 | 0.78 |
Total Current Assets | 891.27 | 884.74 | 899.14 | 972.58 | 282.54 | 230.41 |
Property, Plant & Equipment | 72.83 | 82.22 | 92.72 | 100.91 | 87.64 | 71.1 |
Long-Term Investments | - | - | 40.77 | - | - | - |
Other Intangible Assets | 0.3 | 0.41 | 0.45 | 0.66 | 0.6 | 0.52 |
Long-Term Deferred Tax Assets | 19.91 | 20.24 | 12.96 | 9.63 | 3.23 | 6.15 |
Long-Term Deferred Charges | 5.86 | 6.74 | 8.3 | 3.73 | 3.92 | 0.7 |
Other Long-Term Assets | - | - | 0.38 | 1.21 | 0.68 | 1.91 |
Total Assets | 990.18 | 994.36 | 1,055 | 1,089 | 378.61 | 310.79 |
Accounts Payable | 2.03 | 3.04 | 4.09 | 11.38 | 9.84 | 7.96 |
Accrued Expenses | 8.41 | 55.68 | 58.65 | 65.77 | 36.96 | 43.45 |
Short-Term Debt | - | - | - | - | - | 3.84 |
Current Portion of Leases | 1.22 | 1.91 | 2.93 | 2.6 | 1.88 | - |
Current Income Taxes Payable | 2.82 | 0.25 | 1 | 1.12 | 2.39 | 0.01 |
Current Unearned Revenue | 3.98 | 9.01 | 5.58 | 7.33 | 9.22 | 14.45 |
Other Current Liabilities | 45.76 | 4.52 | 6.21 | 7.26 | 6.02 | 7.36 |
Total Current Liabilities | 64.22 | 74.42 | 78.45 | 95.46 | 66.31 | 77.07 |
Long-Term Leases | 3.13 | 2.33 | 4.09 | 7.91 | 2.11 | - |
Long-Term Unearned Revenue | 4.45 | 5.72 | 9.42 | 22.2 | 22.2 | 18 |
Long-Term Deferred Tax Liabilities | - | - | - | 1.72 | - | - |
Other Long-Term Liabilities | 0.01 | 0.01 | 0.01 | 0.05 | 0.24 | 0.68 |
Total Liabilities | 71.82 | 82.48 | 91.97 | 127.34 | 90.86 | 95.75 |
Common Stock | 40.07 | 40 | 40 | 40 | 30 | 30 |
Additional Paid-In Capital | 781.13 | 777.44 | 773.7 | 776.23 | 135.44 | 127.19 |
Retained Earnings | 133.01 | 129.87 | 149.39 | 146.13 | 122.8 | 58.18 |
Treasury Stock | -35.66 | -35.66 | - | - | - | - |
Comprehensive Income & Other | -0.2 | 0.23 | -0.35 | -0.97 | -0.49 | -0.34 |
Shareholders' Equity | 918.36 | 911.88 | 962.74 | 961.38 | 287.75 | 215.03 |
Total Liabilities & Equity | 990.18 | 994.36 | 1,055 | 1,089 | 378.61 | 310.79 |
Total Debt | 4.35 | 4.24 | 7.02 | 10.51 | 3.99 | 3.84 |
Net Cash (Debt) | 779.11 | 797.51 | 778.42 | 819.4 | 193.95 | 168.13 |
Net Cash Growth | 15.77% | 2.45% | -5.00% | 322.47% | 15.36% | 126.16% |
Net Cash Per Share | 19.93 | 20.42 | 19.79 | 21.42 | 6.39 | 5.59 |
Filing Date Shares Outstanding | 38.78 | 38.71 | 40 | 40 | 30 | 30 |
Total Common Shares Outstanding | 38.78 | 38.71 | 40 | 40 | 30 | 30 |
Working Capital | 827.04 | 810.33 | 820.69 | 877.12 | 216.23 | 153.34 |
Book Value Per Share | 23.68 | 23.56 | 24.07 | 24.03 | 9.59 | 7.17 |
Tangible Book Value | 918.05 | 911.47 | 962.29 | 960.72 | 287.15 | 214.51 |
Tangible Book Value Per Share | 23.67 | 23.55 | 24.06 | 24.02 | 9.57 | 7.15 |
Buildings | - | 58.85 | 58.85 | 58.47 | 58.47 | 38.19 |
Machinery | - | 74.51 | 71.85 | 67.39 | 48.02 | 32.51 |
Construction In Progress | - | 0.41 | - | - | - | 18.38 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.